"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 41 | 41 |
| 1996 | 0 | 46 | 46 |
| 1997 | 0 | 55 | 55 |
| 1998 | 0 | 52 | 52 |
| 1999 | 0 | 58 | 58 |
| 2000 | 0 | 60 | 60 |
| 2001 | 1 | 66 | 67 |
| 2002 | 0 | 96 | 96 |
| 2003 | 0 | 119 | 119 |
| 2004 | 0 | 114 | 114 |
| 2005 | 0 | 122 | 122 |
| 2006 | 0 | 143 | 143 |
| 2007 | 0 | 133 | 133 |
| 2008 | 0 | 194 | 194 |
| 2009 | 0 | 177 | 177 |
| 2010 | 0 | 173 | 173 |
| 2011 | 0 | 223 | 223 |
| 2012 | 0 | 242 | 242 |
| 2013 | 0 | 272 | 272 |
| 2014 | 0 | 256 | 256 |
| 2015 | 0 | 273 | 273 |
| 2016 | 0 | 301 | 301 |
| 2017 | 0 | 263 | 263 |
| 2018 | 0 | 317 | 317 |
| 2019 | 0 | 304 | 304 |
| 2020 | 0 | 274 | 274 |
| 2021 | 0 | 201 | 201 |
| 2022 | 0 | 63 | 63 |
| 2023 | 0 | 52 | 52 |
| 2024 | 0 | 215 | 215 |
| 2025 | 0 | 70 | 70 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma. Cancer Biomark. 2025 Jun; 42(6):18758592251344936.
-
Diagnostic Confidence of Contrast-Enhanced T1-Weighted MRI for the Detection of Brain Metastases: 3D FSE versus 3D GRE-Based Sequences. AJNR Am J Neuroradiol. 2025 Jun 03; 46(6):1231-1237.
-
[18F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF-Targeted Therapy. AJNR Am J Neuroradiol. 2025 Jun 03; 46(6):1260-1267.
-
Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course. Rheumatology (Oxford). 2025 Jun 01; 64(6):3685-3690.
-
Long-Term Clinical Outcomes of Adults Hospitalized for COVID-19 Pneumonia. Emerg Infect Dis. 2025 Jun; 31(6):1158-1168.
-
Comparison of combined intravenous and intra-arterial thrombolysis with intravenous thrombolysis alone in stroke patients undergoing mechanical thrombectomy: a propensity-matched analysis. J Neurointerv Surg. 2025 Jun 01; 17(e2):e261-e268.
-
Mechanical thrombectomy in elderly stroke patients with low ASPECTS: insights from STAR. J Neurointerv Surg. 2025 Jun 01; 17(e2):e206-e215.
-
Real-world effectiveness of darolutamide in metastatic castration-resistant prostate cancer. Endocr Relat Cancer. 2025 Jun 01; 32(6).
-
Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France. Blood Adv. 2025 May 27; 9(10):2530-2541.
-
The role of PD-1/PD-L1 in overshooting osteoclastogenesis in periprosthetic joint infections. Commun Biol. 2025 May 22; 8(1):786.